Erlotinib Induces Synthetic Lethality With the Poly(ADP-Ribose) Polymerase (PARP) Inhibitor ABT-888 in Esophageal Cancer

被引：1
|
作者：
Whitley, A. C. [1 ]
Jackson, J. [1 ]
Trummell, H. [1 ]
Bonner, J. [1 ]
Yang, E. S. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S165 / S166
页数：2
相关论文
共 50 条
  • [1] Cetuximab induces synthetic lethality with the poly (ADP-Ribose) polymerase (PARP) inhibitor ABT-888 in head and neck cancer
    Whitley, Alexander C.
    Nowsheen, Somaira
    Trummell, Hoa
    LoBuglio, Albert
    Bonner, James A.
    Yang, Eddy S.
    CANCER RESEARCH, 2011, 71
  • [2] Discovery and SAR of ABT-888, an inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer
    Zhu, Gui-Dong
    Gong, Jianchun
    Gandhi, Viraj B.
    Luo, Yan
    Liu, Xuesong
    Shi, Yan
    Klinghofer, Vered
    Johnson, Eric F.
    Frost, David
    Donawho, Cherrie
    Rodriguez, Luis
    Bukofzer, Gail
    Jarvis, Ken
    Bouska, Jennifer
    Olson, Amanda
    Marsh, Kennan C.
    Park, Chang
    Rosenberg, Saul
    Giranda, Vincent L.
    Penning, Thomas D.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 716 - 716
  • [3] ABT-888: A potent and orally efficacious inhibitor of poly(ADP-ribose)polymerase
    Penning, Thomas D.
    Zhu, Gui-Dong
    Gandhi, Viraj B.
    Gong, Jianchun
    Liu, Xuesong
    Shi, Yan
    Klinghofer, Vered
    Johnson, Eric F.
    Donawho, Cherrie K.
    Frost, David J.
    Bontecheva-Diaz, Velkitchka
    Bouska, Jennifer J.
    Osterling, Donald J.
    Olson, Amanda M.
    Marsh, Kerman C.
    Luo, Yan
    Giranda, Vincent L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [4] Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma
    Barazzuol, Lara
    Jena, Raj
    Burnet, Neil G.
    Meira, Lisiane B.
    Jeynes, Jonathan C. G.
    Kirkby, Karen J.
    Kirkby, Norman F.
    RADIATION ONCOLOGY, 2013, 8
  • [5] Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma
    Lara Barazzuol
    Raj Jena
    Neil G Burnet
    Lisiane B Meira
    Jonathan C G Jeynes
    Karen J Kirkby
    Norman F Kirkby
    Radiation Oncology, 8
  • [6] Preliminary results of a phase I trial of ABT-888, a poly(ADP-ribose) polymerase (PARP) inhibitor, in combination with cyclophosphamide.
    Tan, A. R.
    Gibbon, D.
    Stein, M. N.
    Moss, R. A.
    Karantza, V.
    Lin, H.
    Gounder, M.
    Chen, A. P.
    Egorin, M. J.
    DiPaola, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Interference with repair of sub-lethal radiation damage by ABT-888, an inhibitor of poly(ADP-ribose) polymerase (PARP), and theobromine
    Patel, Ravi
    Chiu, Song-mao
    Machtay, Mitchell
    Oleinick, Nancy
    CANCER RESEARCH, 2012, 72
  • [8] Phase 0 pharmacodynamic, pharmacokinetic study of ABT-888, an inhibitor of poly (ADP-ribose) polymerase (PARP), in patients with advanced malignancies
    Kummar, S.
    Gutierrez, M.
    Kinders, R.
    Rubinstein, L.
    Parchment, R. E.
    Phillips, L.
    Ji, J.
    Chen, A.
    Homeffer, Y.
    Juwara, L.
    Yancey, M.
    Murgo, A. J.
    Collins, J. M.
    Tomaszewski, J. E.
    Doroshow, J. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 20 - 20
  • [9] Preclinical activity of the poly (ADP-ribose) polymerase (PARP) inhibitor ABT-888 in combination with irinotecan in ovarian and triple negative breast cancers
    Nechiporchik, N.
    Lieb, K.
    Marquette, L.
    Polin, L.
    Peters, G. J.
    Chen, A.
    Ethier, S. P.
    LoRusso, P. M.
    Burger, A. M.
    EJC SUPPLEMENTS, 2010, 8 (07): : 64 - 64
  • [10] Recruitment experience in a phase 0 trial of ABT-888, an inhibitor of poly (ADP-ribose) polymerase (PARP), in patients (pts) with advanced malignancies
    Gutierrez, M.
    Kummar, S.
    Horneffer, Y.
    Juwara, L.
    Chen, A.
    Melillo, G.
    Pickeral, O.
    Tomaszewski, J. E.
    Murgo, A. J.
    Doroshow, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345